The role of copper in disulfiram-induced toxicity and radiosensitization of cancer cells

Journal of Nuclear Medicine

Volumn 54, Issue 6, 2013, Pages 953-960

  Rae, Colin ^a   Tesson, Mathias ^a   Babich, John W ^b   Boyd, Marie ^c   Sorensen, Annette ^c   Mairs, Robert J ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b A Subsidiary of Lantheus Holdings   (United States)

^c UNIVERSITY OF STRATHCLYDE   (United Kingdom)

Author keywords

131I metaiodobenzylguanidine; Copper; Disulfiram; Neuroblastoma radiosensitizer

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 131; CARRIER PROTEIN; COPPER; COPPER CHLORIDE; DISULFIRAM; NORADRENALINE TRANSPORTER; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG POTENTIATION; EXTERNAL BEAM RADIOTHERAPY; FEMALE; GAMMA IRRADIATION; GLIOBLASTOMA; GLIOMA CELL; HUMAN; HUMAN CELL; MOUSE; NEUROBLASTOMA; NEUROBLASTOMA CELL; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RADIOSENSITIZATION;

131I-METAIODOBENZYLGUANIDINE; COPPER; DISULFIRAM; NEUROBLASTOMA RADIOSENSITIZER;

3-IODOBENZYLGUANIDINE; ANIMALS; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; COPPER; DISULFIRAM; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GAMMA RAYS; HUMANS; MICE; RADIATION TOLERANCE; SPHEROIDS, CELLULAR;

EID: 84878660014     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.112.113324     Document Type: Article

References (37)

1. Hald J, Jacobsen E. A drug sensitizing the organism to ethyl alcohol. Lancet. 1948;2:1001-1004.
2. Chen SH, Liu SH, Liang YC, Lin JK, Lin-Shiau SY. Oxidative stress and c-Jun-amino-terminal kinase activation involved in apoptosis of primary astrocytes induced by disulfiram-Cu2+ complex. Eur J Pharmacol. 2001;414:177-188. (Pubitemid 32181884)
3. Cen D, Gonzalez RI, Buckmeier JA, Kahlon RS, Tohidian NB, Meyskens FL Jr. Disulfiram induces apoptosis in human melanoma cells: a redox-related process. Mol Cancer Ther. 2002;1:197-204.
4. Chen D, Cui QC, Yang H, Dou QP. Disulfiram, a clinically used anti-alcoholism drug and copper-binding agent, induces apoptotic cell death in breast cancer cultures and xenografts via inhibition of the proteasome activity. Cancer Res. 2006;66:10425-10433. (Pubitemid 44799763)
5. Lovborg H, Oberg F, Rickardson L, Gullbo J, Nygren P, Larsson R. Inhibition of proteasome activity, nuclear factor-KB translocation and cell survival by the antialcoholism drug disulfiram. Int J Cancer. 2006;118:1577-1580.
6. Cvek B, Dvorak Z. The value of proteasome inhibition in cancer: can the old drug, disulfiram, have a bright new future as a novel proteasome inhibitor? Drug Discov Today. 2008;13:716-722.
7. Wang W, McLeod HL, Cassidy J. Disulfiram-mediated inhibition of NF-κB activity enhances cytotoxicity of 5-fluorouracil in human colorectal cancer cell lines. Int J Cancer. 2003;104:504-511. (Pubitemid 36323923)
8. Guo X, Xu B, Pandey S, et al. Disulfiram/copper complex inhibiting NFκB activity and potentiating cytotoxic effect of gemcitabine on colon and breast cancer cell lines. Cancer Lett. 2010;290:104-113.
9. Børup C, Kaiser A, Jensen E. Long-term Antabuse treatment: tolerance and reasons for withdrawal. Acta Psychiatr Scand Suppl. 1992;369:47-49.
10. Daniel KG, Chen D, Yan B, Dou QP. Copper-binding compounds as proteasome inhibitors and apoptosis inducers in human cancer. Front Biosci. 2007;12:135-144. (Pubitemid 46852833)
11. Gupte A, Mumper RJ. Elevated copper and oxidative stress in cancer cells as a target for cancer treatment. Cancer Treat Rev. 2009;35:32-46.
12. Kumatori A, Tanaka K, Inamura N, Sone S, Ogura T, Matsumoto T. Abnormally high expression of proteasomes in human leukemic cells. Proc Natl Acad Sci USA. 1990;87:7071-7075.
13. McBride WH, Iwamoto KS, Syljuasen R, Pervan M, Pajonk F. The role of the ubiquitin/proteasome system in cellular responses to radiation. Oncogene. 2003;22:5755-5773. (Pubitemid 37176698)
14. Lin PS, Kwock L, Butterfield CE. Diethylthiocarbamate enhancement of radiation and hyperthermic effects on Chinese hamster cell in vitro. Radiat Res. 1979;77:501-511. (Pubitemid 9158697)
15. 131I-MIBG is effective for disease palliation in highly refractory neuroblastoma. J Pediatr Hematol Oncol. 2003;25:769-773.
16. Maris JM, Matthay KK. Molecular biology of neuroblastoma. J Clin Oncol. 1999;17:2264-2279. (Pubitemid 29318861)
17. Loo TW, Clarke DM. Blockage of drug resistance in vitro by disulfiram, a drug used to treat alcoholism. J Natl Cancer Inst. 2000;92:898-902. (Pubitemid 30429189)
18. Chan HS, Grogan TM, DeBoer G, Haddad G, Gallie BL, Ling V. Diagnosis and reversal of multidrug resistance in pediatric cancers. Eur J Cancer. 1996;32:1051-1061.
19. 131I]meta- iodobenzylguanidine and topotecan combination treatment of tumors expressing the noradrenaline transporter. Clin Cancer Res. 2005;11:7929-7937.
20. 131I]meta- iodobenzylguanidine and topotecan in combination. Br J Radiol. 2008;81:S28-S35.
21. Neshasteh-Riz A, Angerson WJ, Reeves JR, Smith G, Rampling R, Mairs RJ. Incorporation of iododeoxyuridine in multicellular glioma spheroids: implications for DNA-targeted radiotherapy using Auger electron emitters. Br J Cancer. 1997;75:493-499. (Pubitemid 27085288)
22. 131I meta-iodobenzylguanidine. Gene Ther. 1999;6:1147-1152.
23. Boyd M, Mairs SC, Stevenson K, Livingstone A. McCluskey AG, Ross SC and Mairs RJ. Transfectant mosaic spheroids: a new model for the evaluation of bystander effects in experimental gene therapy. J Gene Med. 2002;4:567-576. (Pubitemid 40268383)
24. Yuhas JM, Li AP, Martinez AO, Ladman AJ. A simplified method for production and growth of multicellular tumor spheroids. Cancer Res. 1977;37:3639-3643. (Pubitemid 8198426)
25. Ballangrud AM, Yang WH, Dnistrian A, Lampen NM, Sgouros G. Growth and characterization of LNCaP prostate cancer cell spheroids. Clin Cancer Res. 1999;5:3171s-3176s. (Pubitemid 29493912)
26. Chou TC, Talalay P. Quantitative analysis of dose-effect relationship: the combined effects of multiple drugs or enzyme inhibitors. Adv Enzyme Regul. 1984;22:27-55.
27. Rickardson L, Wickstrom M, Larsson R, Lovborg H. Image-based screening for the identification of novel proteasome inhibitors. J Biomol Screen. 2007;12:203-210. (Pubitemid 46364423)
28. Cohen JD, Robins HI. Cytotoxicity of diethyldithiocarbamate in human versus rodent cell lines. Invest New Drugs. 1990;8:137-142. (Pubitemid 20184223)
29. Chung KC, Park JH, Kim CH, et al. Novel biphasic effect of pyrrolidine dithiocarbamate on neuronal cell viability is mediated by the differential regulation of intracellular zinc and copper ion levels, NF-κB and MAP kinases. J Neurosci Res. 2000;59:117-125. (Pubitemid 30038871)
30. Faiman MD, Dodd DE, Minor SS, Hanzlik R. Radioactive and nonradioactive methods for the in vivo determination of disulfiram, diethyldithiocarbamate, and diethyldithiocarbamate-methyl ester. Alcohol Clin Exp Res. 1978;2:366-369. (Pubitemid 9072611)
31. Faiman MD, Jensen C, Lacoursiere RB. Elimination kinetics of disulfiram in alcoholics after single and repeated doses. Clin Pharmacol Ther. 1984;36:520-526. (Pubitemid 15201164)
32. Oh H, Bang JS, Choi HM, Yang HI, Yoo MC, Kim KS. Fetal bovine serum requirement for pyrridoline dithiocarbamate-induced apoptotic cell death of MCF-7 breast tumor cells. Eur J Pharmacol. 2010;649:135-139.
33. Cen D, Brayton D, Shahandeh B, Meyskens FL Jr, Farmer PJ. Disulfiram facilitates intracellular Cu uptake and induces apoptosis in human melanoma cells. J Med Chem. 2004;47:6914-6920. (Pubitemid 40053779)
34. Glassman AB, Rydzewski RS, Bennett CE. Trace metal levels in commercially prepared tissue culture medium. Tissue Cell. 1980;12:613-617. (Pubitemid 11185325)
35. Yu Z, Wang F, Milacic V, et al. Evaluation of copper-dependent proteasome-inhibitory and apoptosis-inducing activities of novel pyrrolidine dithiocarbamate analogues. Int J Mol Med. 2007;20:919-925.
36. Sullivan JF, Blotcky AJ, Jetton MM, Hahn HK, Burch RE. Serum levels of selenium, calcium, copper, magnesium, manganese and zinc in various human diseases. J Nutr. 1979;109:1432-1437. (Pubitemid 9241700)
37. Rannug A, Rannug U. Enzyme inhibition as a possible mechanism of the mutagenicity of dithiocarbamate acid derivatives in Salmonella typhimurium. Chem Biol Interact. 1984;49:329-340. (Pubitemid 14104884)